Perrigo (PRGO) Long-Term Deferred Tax (2013 - 2026)
Perrigo (PRGO) posted quarterly Long-Term Deferred Tax of $4.7 million for Q1 2026, down 12.96% year-over-year from $5.4 million in Q1 2025, and up 42.42% quarter-over-quarter from $3.3 million in Q4 2025.
Perrigo (PRGO) Long-Term Deferred Tax (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Long-Term Deferred Tax for 14 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Deferred Tax fell 12.96% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (down 12.96% YoY), while the FY2025 annual figure was $3.3 million, down 35.29% from the prior year.
- Long-Term Deferred Tax improved to $4.7 million in Q1 2026 per PRGO's latest filing, from $3.3 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $64.2 million in Q3 2025 and bottomed at $3.3 million in Q4 2025.
- Historically, Long-Term Deferred Tax has averaged $15.8 million across 5 years, with a median of $6.9 million in 2022.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax tumbled 88.31% — and 2024, when it soared 359.02%.
- Perrigo's Long-Term Deferred Tax stood at $7.1 million in 2022, then surged by 263.38% to $25.8 million in 2023, then tumbled by 80.23% to $5.1 million in 2024, then tumbled by 35.29% to $3.3 million in 2025, then surged by 42.42% to $4.7 million in 2026.
- Business Quant data shows PRGO's Long-Term Deferred Tax at $4.7 million in Q1 2026, $3.3 million in Q4 2025, and $64.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Perrigo | 1.94 Bn | 1.54 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 6.30 Mn |
| Mar 28, 2026 | 4.70 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 27, 2025 | 64.20 Mn |
| Jun 28, 2025 | 48.10 Mn |
| Mar 29, 2025 | 5.40 Mn |
| Dec 31, 2024 | 5.10 Mn |
| Sep 28, 2024 | 22.40 Mn |
| Jun 29, 2024 | 13.80 Mn |
| Mar 30, 2024 | 28.00 Mn |
| Dec 31, 2023 | 25.80 Mn |
| Sep 30, 2023 | 6.80 Mn |
| Jul 1, 2023 | 6.30 Mn |
| Apr 1, 2023 | 6.10 Mn |
| Dec 31, 2022 | 7.10 Mn |
| Oct 1, 2022 | 7.70 Mn |
| Jul 2, 2022 | 6.90 Mn |
| Apr 2, 2022 | 6.70 Mn |
| Dec 31, 2021 | 6.50 Mn |
| Oct 2, 2021 | 40.20 Mn |